RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,550 | $3,927 | $4,796 | $4,689 |
| % Growth | 15.9% | -18.1% | 2.3% | – |
| Cost of Goods Sold | $3,767 | $3,202 | $3,936 | $3,954 |
| Gross Profit | $783 | $725 | $860 | $735 |
| % Margin | 17.2% | 18.5% | 17.9% | 15.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $640 | $539 |
| Sales & Mktg Exp. | $0 | $0 | $640 | $539 |
| Other Operating Expenses | $839 | $686 | $97 | $4 |
| Operating Expenses | $839 | $686 | $737 | $543 |
| Operating Income | -$56 | $39 | $123 | $192 |
| % Margin | -1.2% | 1% | 2.6% | 4.1% |
| Other Income/Exp. Net | -$248 | -$35 | -$4 | -$1 |
| Pre-Tax Income | -$304 | $4 | $119 | $191 |
| Tax Expense | -$14 | $0 | $27 | $41 |
| Net Income | -$290 | $4 | $92 | $150 |
| % Margin | -6.4% | 0.1% | 1.9% | 3.2% |
| EPS | -2.17 | 0.034 | 0.79 | 1.29 |
| % Growth | -6,445% | -95.7% | -38.8% | – |
| EPS Diluted | -2.17 | 0.034 | 0.79 | 1.29 |
| Weighted Avg Shares Out | 133 | 117 | 116 | 116 |
| Weighted Avg Shares Out Dil | 133 | 119 | 116 | 116 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $30 | $32 | $4 | $0 |
| Depreciation & Amortization | $87 | $67 | $86 | $81 |
| EBITDA | $117 | $134 | $209 | $272 |
| % Margin | 2.6% | 3.4% | 4.4% | 5.8% |